OpenLegislation

Division (iii)

United Kingdom

Original text. Later amendments are not shown.

Co-formulants must where possible, be identified either by their International Chemical Identification as given in F1the GB mandatory classification and labelling list, or, if not included in that F2list, in accordance with both IUPAC and CA nomenclature. Their structure or structural formula must be provided. For each component of the co-formulants the relevant EC (EINECS or ELINCS) number and CAS number where they exist, must be provided. Where the information provided does not fully identify a co-formulant, an appropriate specification must be provided. The trade name of co-formulants, where they exist, must also be provided.

Annotations

Textual amendments

F1

Words in Annex Pt. B point 1.4(iii) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 177(2)(b)(i)(aa) (as amended by S.I. 2020/1567, reg. 1(2), Sch. 2 para. 62); 2020 c. 1, Sch. 5 para. 1(1)

F2

Word in Annex Pt. B point 1.4(iii) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 177(2)(b)(i)(bb); 2020 c. 1, Sch. 5 para. 1(1)